With the help of our corporate partners, we have made great strides in improving the lives of the millions of people impacted by epilepsy. We are stronger because of our partnerships. Our partnerships enable us to raise awareness, support research and innovation which brings us closer to new therapies and a cure, advocate for lasting change, and provide critical education and services in local communities across the United States. We celebrate our Corporate Partnerships and welcome companies to join us as we fight to overcome the challenges living with epilepsy, stop seizures, find cures and save lives.

Read more about our current Corporate Partners below.

The Lyte Guild

In 1578, a British botanist, Henry Lyte, translated Flemish physician Rembert Dodoens' famous herbal text, Cruydeboek. In his translation, Lyte showed a clear preference for the term epilepsy rather than the common-terminology of "falling sickness". Lyte was the first to trigger a perception change from being one of a mysterious "sacred disease" toward a medically explained disease/condition. The Epilepsy Foundation continues the fight to change perception and reduce stigma by serving as a catalyst for research and new therapies. The Foundation welcomes partners across industries to join its mission.

The Lyte Guild is special membership that recognizes corporate partners who committed $500,000 or more joining the quest to end epilepsy. The following corporate partners are members of the Lyte Guild:

Lundbeck

Lundbeck

Sunovion

Sunovion

UCB

UCB

Upsher-Smith

Upsher-Smith

National Corporate Partners

Our National Corporate Partners demonstrate a high level of commitment to our mission through financial support and efforts to raise awareness. The following National Corporate Partners have committed $100,000–$499,999 toward joining the quest to end epilepsy:

Community Partners

Our Community Partners show the true call to action for the epilepsy community by devoting their mission to helping the diverse spectrum of epilepsies. The following Community Partners have committed $25,000–$99,999 toward joining the quest to end epilepsy:

  • Acorda
  • Adamas
  • Alexza Pharmceuticals
  • Anavex Life Sciences
  • Dr. Reddy's Laboratories
  • GW Pharma
  • Insys
  • Medtronic
  • Neurelis
  • Ovid Therapuetics
  • PhRMA
  • Pronutria BioSciences
  • Supernus
  • Zogenix

Strategic Partners

Our Strategic Partners lead the way in supporting research, finding new therapies, and breaking down social barriers as a demonstration of their company’s commitment to ending the fight against seizures.

  • BioTechnology
  • Danny Did
  • Envoy Airlines
  • National Association of Epilepsy Centers
  • Neuropace
  • Pediatric Epilepy Research Foundation
  • Rare Patient Voice
  • SAMi
  • Smart Monitor
  • Ultragenyx

Partnership Opportunities

National sponsorship offers numerous opportunities to enhance your company's visibility with people living with epilepsy. It provides an easy way to interact with a targeted group of patients, caregivers, and health care professionals, to introduce your brand or service.

  • Mission Support
  • Events Sponsorship
  • Educational Grants
  • Research and New Therapy
  • Digital Sponsorship (epilepsy.com)
Become a Partner

The Epilepsy Foundation offers companies a meaningful investment with the leading advocacy organization for people living with epilepsy. Corporate membership directly supports epilepsy programs, education, care provided through our more than 45 affiliated networks, and the discovery of new treatments and therapies in a time frame that matters, while providing companies with a range of benefits designed to help members reach their key business goals.

Contact Us

Corporations and foundations that partner with the Epilepsy Foundation distinguish their organizations as socially responsible and earn the gratitude and loyalty of nearly 3 million Americans living with epilepsy, plus their families, friends and caregivers.

For more information on the wide range of opportunities to support the work of the Epilepsy Foundation and to discuss corporate and foundation funding, please contact Jeanette Stoltzfus or call 301-459-3700.